ExodusPoint Capital Management, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$887
-78.7%
10,423
-79.3%
0.01%
-79.4%
Q1 2023$4,157
+39.4%
50,232
+32.5%
0.03%
-20.9%
Q4 2022$2,981
-99.0%
37,900
+561.9%
0.04%
+1333.3%
Q4 2021$304,000
-54.5%
5,726
-4.8%
0.00%
-70.0%
Q1 2021$668,000
-85.4%
6,015
-84.4%
0.01%
-77.8%
Q4 2020$4,570,000
-27.9%
38,488
-47.0%
0.04%
-64.6%
Q3 2020$6,339,000
+84.3%
72,659
+89.2%
0.13%
+42.7%
Q2 2020$3,439,000
-10.5%
38,401
+14.8%
0.09%
+23.6%
Q4 2019$3,842,00033,4370.07%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders